Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend of $0.75 per share. The dividend will be payable on October 21, 2024 to shareholders of record as of October 4, 2024. This announcement demonstrates Quest Diagnostics' commitment to returning value to its shareholders and reflects the company's financial stability and confidence in its future prospects.
Quest Diagnostics (NYSE: DGX), uno dei principali fornitori di servizi informatici diagnostici, ha annunciato un dividendo in contante trimestrale di $0.75 per azione. Il dividendo sarà pagato il 21 ottobre 2024 agli azionisti registrati al 4 ottobre 2024. Questo annuncio dimostra l'impegno di Quest Diagnostics nel restituire valore ai propri azionisti e riflette la stabilità finanziaria dell'azienda e la fiducia nelle sue prospettive future.
Quest Diagnostics (NYSE: DGX), un proveedor líder de servicios de información diagnóstica, ha anunciado un dividendo en efectivo trimestral de $0.75 por acción. El dividendo se pagará el 21 de octubre de 2024 a los accionistas que posean acciones al 4 de octubre de 2024. Este anuncio demuestra el compromiso de Quest Diagnostics de devolver valor a sus accionistas y refleja la estabilidad financiera de la empresa y la confianza en sus perspectivas futuras.
Quest Diagnostics (NYSE: DGX), 주요 진단 정보 서비스 제공업체가 분기별 현금 배당금으로 주당 $0.75를 발표했습니다. 배당금은 2024년 10월 21일에 2024년 10월 4일 기준의 주주들에게 지급됩니다. 이 발표는 Quest Diagnostics가 주주에게 가치를 반환하는 데 대한 의지를 보여주며, 회사의 재정적 안정성과 미래 전망에 대한 자신감을 반영합니다.
Quest Diagnostics (NYSE: DGX), un fournisseur leader de services d'information diagnostique, a annoncé un dividende trimestriel en espèces de 0,75 $ par action. Le dividende sera versé le 21 octobre 2024 aux actionnaires dont le nom figure au registre au 4 octobre 2024. Cette annonce démontre l'engagement de Quest Diagnostics à restituer de la valeur à ses actionnaires et reflète la stabilité financière de l'entreprise ainsi que sa confiance dans ses perspectives futures.
Quest Diagnostics (NYSE: DGX), ein führender Anbieter von diagnostischen Informationsdiensten, hat eine vierteljährliche Bardividende von 0,75 $ pro Aktie angekündigt. Die Dividende wird am 21. Oktober 2024 an die Aktionäre ausgezahlt, die am 4. Oktober 2024 im Aktienregister stehen. Diese Ankündigung zeigt das Engagement von Quest Diagnostics, seinen Aktionären Wert zurückzugeben, und spiegelt die finanzielle Stabilität des Unternehmens sowie das Vertrauen in seine zukünftigen Perspektiven wider.
- Consistent dividend payment indicates financial stability
- Shareholder value creation through regular cash distributions
- Maintained dividend level suggests company confidence
- None.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from the world's largest database of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302222903.html
SOURCE Quest Diagnostics
FAQ
What is the amount of Quest Diagnostics' quarterly dividend for 2024?
When will Quest Diagnostics (DGX) pay its next dividend?
What is the record date for Quest Diagnostics' upcoming dividend?
How often does Quest Diagnostics (DGX) pay dividends?
